Geode Capital Management
FRLN

Geode Capital Management’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Geode Capital Management’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,141
Closed -$139K – 4880
2021
Q2 		$139K Sell
1,141
-52
-4% -$8.08K ﹤0.01% 4469
2021
Q1 		$220K Hold
1,193
– – ﹤0.01% 4084
2020
Q4 		$326K Hold
1,193
– – ﹤0.01% 3730
2020
Q3 		$279K Buy
+1,193
New +$299K ﹤0.01% 3613

Other funds holding FRLN

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management's FRLN Position: Q3 2021 in Review

Geode Capital Management sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q3 2021, closing a stake of 1,141 shares — an estimated $139K sold.

Geode Capital Management first reported a position in FRLN in Q3 2020 and held it in 4 quarters. The position peaked at $326K in Q4 2020. 20 funds tracked by Wall St. Rank hold FRLN as of Q3 2021.

  • Geode Capital Management reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Geode Capital Management sold 1,141 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q3 2021, an estimated $139K.
  • Geode Capital Management first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2020 and held it in 4 quarters.
  • Geode Capital Management's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $326K in Q4 2020.
  • 20 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q3 2021.

Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.